SEC 13F Intelligence

Loews Corp / BMY

Loews Corp’s Bristol-Myers Squibb Co Position

Does Loews Corp own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 280.0K shares worth $16M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$16M
Q3 2023
Shares
280.0K
% of Portfolio
+0.16%
Quarters Held
18
position exited

Position History BMY

Reported value by quarter
Q2 ’19: $17MQ2 ’19Q3 ’19: $23MQ4 ’19: $17MQ1 ’20: $18MQ1 ’20Q2 ’20: $17MQ3 ’20: $16MQ4 ’20: $18MQ4 ’20Q1 ’21: $21MQ2 ’21: $22MQ3 ’21: $21MQ3 ’21Q4 ’21: $22MQ1 ’22: $22MQ2 ’22: $19MQ2 ’22Q3 ’22: $12MQ4 ’22: $12MQ1 ’23: $17MQ1 ’23Q2 ’23: $14MQ3 ’23: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023280.0K$16M+0.16%
Q2 2023215.0K$14M+0.14%
Q1 2023240.0K$17M+0.17%
Q4 2022170.0K$12M+0.11%
Q3 2022170.0K$12M+0.13%
Q2 2022245.0K$19M+0.17%
Q1 2022305.0K$22M+0.18%
Q4 2021355.0K$22M+0.20%
Q3 2021350.0K$21M+0.19%
Q2 2021330.0K$22M+0.19%
Q1 2021340.0K$21M+0.19%
Q4 2020290.0K$18M+0.18%
Q3 2020270.0K$16M+0.21%
Q2 2020285.0K$17M+0.20%
Q1 2020330.5K$18M+0.23%
Q4 2019260.0K$17M+0.14%
Q3 2019460.0K$23M+0.18%
Q2 2019370.0K$17M+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Loews Corp’s full portfolio or all institutional holders of BMY.